GETREAL
Incorporating real-life clinical data into drug development
Site Search
Site Search
Displaying results 771 - 780 of 893
31st Edition – January 2014
Table of contents:
- Investing in excellence – IMI offers SMEs VC networking opportunity
- IMI editorial in Science Translational Medicine
- Top Portuguese and Finnish Scientists to Lead IMI Scientific Committee
- EAPM launches survey on personalised medicine
- IMI video: Paving the way for new treatments for autism
- News from the projects
Top Portuguese and Finnish scientists to lead IMI Scientific Committee
For immediate release IMI/OUT/2014-00118 Professor Maria Beatriz da Silva Lima of the University of Lisbon in Portugal is elected Chair of the IMI Scientific Committee. Professor Markus Perola of Finland’s National Institute for Health and Welfare is elected Vice Chair. The pair ...
Investing in excellence
IMI Investing in Excellence - SME networking event On 18 February 2014, at Le Méridien hotel, Brussels, IMI and the International Venture Club (IVC) welcomed over 120 leading life science investors, health entrepreneurs, corporate investors and small and medium-sized enterprises ...
IMI/NEWMEDS study: Genetic variants linked with schizophrenia have impact in healthy carriers
IMI/OUT/2013-05633 PRESS RELEASE IMI/NEWMEDS STUDY: GENETIC VARIANTS LINKED WITH SCHIZOPHRENIA HAVE IMPACT IN HEALTHY CARRIERS BRUSSELS, 20 December 2013 – Genetic variants associated with schizophrenia and autism still have an impact on cognitive skills and brain structure in ...
30th Edition – December 2013
Table of contents:
- IMI’s 11th Call for proposals launched
- Join the IMI 11th Call webinars
- Find partners for your consortium
- IMI contributes to G8 Dementia Summit
- How well do patients know IMI and what is in for them?
- Investing in excellence – IMI offers SMEs VC networking opportunity
- Journal paper highlights success of PPP model
- European Lead Factory highlighted in Nature Medicine review of 2013
- Season’s Greetings
- News from the projects
New IMI project to revolutionise clinical trials for Alzheimer’s drugs
IMI/OUT/2013-05326 €53 million project will test new approach to clinical trials for drugs designed to prevent Alzheimer’s disease New approach will allow evaluation of several drugs at once Unique project will see several biotechnology and pharmaceutical companies work together ...
IMI launches €371 million call with focus on Alzheimer’s, arthritis, cancer, and more
IMI/OUT/2013-05415 - Call has total budget of €371 million, meaning IMI is on track to spend its entire €2 billion budget - Topics focus on Alzheimer’s disease, osteoarthritis, cancer, diseases transmitted by animals, antimicrobial resistance, drug discovery, and environmental ...
IMI's 11th Call webinars
From 8 January to 5 February 2014, IMI held webinars on all 11th Call topics as well as on IMI's rules and procedures. All topic webinars featured a presentation of the Call topic by the EFPIA topic coordinator as well as time for questions and answers. The webinars represented ...
IMI welcomes new experts to its Scientific Committee
For immediate release IMI/OUT/2013-05144 New members are leading experts in genetics, cancer, health economics, molecular biology, rheumatology, pharmacology, and bioinformatics. The members are based in Germany, France, Poland, Portugal, Finland, Sweden, Switzerland 12-strong ...